EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SEP‐363856 exerts neuroprotection through the PI3K/AKT/GSK‐3β signaling pathway in a dual‐hit neurodevelopmental model of schizophrenia‐like mice

Mengdie Li iD, Yunxiao Liu, Meng Sun, Yating Yang, Ling Zhang, Yuexia Liu, Fujin Li, Huanzhong Liu

Drug Development Research · 2024

DOI: 10.1002/ddr.22225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2024. Verfasst von Mengdie Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Chaohu Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Glycogen Synthase Kinase 3 beta, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Schizophrenia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Provincial Key Laboratory for Brain Bank Construction and Resource Utilization, the National Clinical Key Specialty Project Foundation (CN).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schizophrenia (SZ) is a serious, destructive neurodevelopmental disorder. Antipsychotic medications are the primary therapy approach for this illness, but it's important to pay attention to the adverse effects as well. Clinical studies for SZ are currently in phase ΙΙΙ for SEP‐363856 (SEP‐856)‐a new antipsychotic that doesn't work on dopamine D 2 receptors. However, the underlying action mechanism of SEP‐856 remains unknown. This study aimed to evaluate the impact and underlying mechanisms of SEP‐856 on SZ‐like behavior in a perinatal MK‐801 treatment combined with social isolation from the weaning to adulthood model (MK‐SI). First, we created an animal model that resembles SZ that combines the perinatal MK‐801 with social isolation from weaning to adulthood. Then, different classical behavioral tests were used to evaluate the antipsychotic properties of SEP‐856. The levels of proinflammatory cytokines (tumor necrosis factor‐α, interleukin‐6, and interleukin‐1β), apoptosis‐related genes (Bax and Bcl‐2), and synaptic plasticity‐related genes (brain‐derived neurotrophic factor [BDNF] and PSD‐95) in the hippocampus were analyzed by quantitative real‐time PCR. Hematoxylin and eosin staining were used to observe the morphology of neurons in the hippocampal DG subregions. Western blot was performed to detect the protein expression levels of BDNF, PSD‐95, Bax, Bcl‐2, PI3K, p‐PI3K, AKT, p‐AKT, GSK‐3β, p‐GSK‐3β in the hippocampus. MK‐SI neurodevelopmental disease model studies have shown that compared with sham group, MK‐SI group exhibit higher levels of autonomic activity, stereotyped behaviors, withdrawal from social interactions, dysregulated sensorimotor gating, and impaired recognition and spatial memory. These findings imply that the MK‐SI model can mimic symptoms similar to those of SZ. Compared with the MK‐SI model, high doses of SEP‐856 all significantly reduced increased activity, improved social interaction, reduced stereotyping behavior, reversed sensorimotor gating dysregulation, and improved recognition memory and spatial memory impairment in MK‐SI mice. In addition, SEP‐856 can reduce the release of proinflammatory factors in the MK‐SI model, promote the expression of BDNF and PSD‐95 in the hippocampus, correct the Bax/Bcl‐2 imbalance, turn on the PI3K/AKT/GSK‐3β signaling pathway, and ultimately help the MK‐SI mice's behavioral abnormalities. SEP‐856 may play an antipsychotic role in MK‐SI “dual‐hit” model‐induced SZ‐like behavior mice by promoting synaptic plasticity recovery, decreasing death of hippocampal neurons, lowering the production of pro‐inflammatory substances in the hippocampal region, and subsequently initiating the PI3K/AKT/GSK‐3β signaling cascade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Synthase Kinase 3 betaPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSchizophreniaSignal TransductionAnimalsFemaleMaleMiceAntipsychotic AgentsBehavior, AnimalDisease Models, AnimalDizocilpine MaleateHippocampusMice, Inbred C57BLNeuroprotective AgentsSocial Isolation

Stichwörter der Autor:innen

PI3K/AKT/GSK‐3βSEP‐363856neuroprotectionschizophrenia

Substanzen

Antipsychotic AgentsDizocilpine MaleateGlycogen Synthase Kinase 3 betaNeuroprotective AgentsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Psychiatry, Chaohu Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Department of Psychiatry, School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, Anhui, China.
  • The Second People's Hospital of Huizhou, Huizhou, Guangdong, China.

ORCID-Profile: Mengdie Li

Förderung

  • Anhui Provincial Key Laboratory for Brain Bank Construction and Resource Utilization
  • the National Clinical Key Specialty Project Foundation (CN)

Zitieren

APA

Li, M., Liu, Y., Sun, M., Yang, Y., Zhang, L., Liu, Y., Li, F., & Liu, H. (2024). SEP‐363856 exerts neuroprotection through the PI3K/AKT/GSK‐3β signaling pathway in a dual‐hit neurodevelopmental model of schizophrenia‐like mice. Drug Development Research. https://doi.org/10.1002/ddr.22225

Vancouver

Li M, Liu Y, Sun M, Yang Y, Zhang L, Liu Y, et al. SEP‐363856 exerts neuroprotection through the PI3K/AKT/GSK‐3β signaling pathway in a dual‐hit neurodevelopmental model of schizophrenia‐like mice. Drug Development Research. 2024. doi:10.1002/ddr.22225

BibTeX
@article{Li2024,
  author = {Li, Mengdie and Liu, Yunxiao and Sun, Meng and Yang, Yating and Zhang, Ling and Liu, Yuexia and Li, Fujin and Liu, Huanzhong},
  title = {SEP‐363856 exerts neuroprotection through the PI3K/AKT/GSK‐3β signaling pathway in a dual‐hit neurodevelopmental model of schizophrenia‐like mice},
  journal = {Drug Development Research},
  year = {2024},
  doi = {10.1002/ddr.22225}
}
Kostenlos starten →